OTC/supplement recalls fall by one-third to 46 in 1996.
This article was originally published in The Tan Sheet
Executive SummaryOTC/SUPPLEMENT RECALLS FALL BY ONE-THIRD TO 46 IN 1996 from 69 in 1995 based on an analysis of FDA's weekly Enforcement Report. The most frequent causes of OTC product and dietary supplement recalls in 1996 were problems with labeling/packaging and potency/content uniformity, which each generated 15 recalls (34% of the total) in 1996. In 1995, labeling/packaging snafus caused 17 recalls (25%), and potency/content uniformity 21 (30%)
You may also be interested in...
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.
Laparoscopic power morcellation to remove uterine fibroids should only be performed with the use of a compatible containment system, and only on women younger than 50, the US FDA said in a newly published safety communication and draft guidance document. See what the president of the gynecologic trade group AAGL, Jubilee Brown, said about it here.